As reported in articles included in our study, CP-treated patients with severe or critical COVID-19 had large reductions in their serum viral load and a negative conversion of viral PCR occurred in most patients at 72 hours after transfusion [8–15, 17, 18, 25, 33, 34]. This evidence concerns the gene CP and COVID-19.